Neuralstem, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the production and differentiation of neural stem cells for the treatment of various neurological diseases. Neuralstem research has produced several novel cellular and pharmaceutical technologies to promote regeneration and healing of neural cells for various diseases. Neuralstem is the first organization to run U.S. Food and Drug Administration (FDA)–approved phase I and II clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) using stem cell technologies.

Neuralstem Cell Therapies and Spinal Cord Delivery Platform and Floating Cannula

Cell therapy involves the injection of cellular material into human patients for the treatment of disease. Neuralstem’s cell therapy technologies specialize in the growing of regionally specific neural stem cells for transplantation into a patient’s central nervous ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles